ISO 27001 Certificate
SOC 1 Type I Certificate
SOC 2 Type II Certificate
PCI DSS
HIPAA
RGPD
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
ISOSOC2 Type 1SOC2 Type 2PCI DSSHIPAAGDPR

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

ICON plc A.I CyberSecurity Scoring

ICON plc

Company Details

Linkedin ID:

icon-plc-2

Employees number:

36,427

Number of followers:

577,622

NAICS:

541714

Industry Type:

Biotechnology Research

Homepage:

iconplc.com

IP Addresses:

0

Company ID:

ICO_2948584

Scan Status:

In-progress

AI scoreICON plc Risk Score (AI oriented)

Between 750 and 799

https://images.rankiteo.com/companyimages/icon-plc-2.jpeg
ICON plc Biotechnology Research
Updated:
  • Powered by our proprietary A.I cyber incident model
  • Insurance preferes TPRM score to calculate premium
globalscoreICON plc Global Score (TPRM)

XXXX

https://images.rankiteo.com/companyimages/icon-plc-2.jpeg
ICON plc Biotechnology Research
  • Instant access to detailed risk factors
  • Benchmark vs. industry & size peers
  • Vulnerabilities
  • Findings

ICON plc Company CyberSecurity News & History

Past Incidents
0
Attack Types
0
No data available
Ailogo

ICON plc Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

🔒
Incident Predictions locked
Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

🔒
A.I. Risk Score Predictions locked
Access Monitoring Plan
statics

Underwriter Stats for ICON plc

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for ICON plc in 2025.

Incidents vs All-Companies Average (This Year)

No incidents recorded for ICON plc in 2025.

Incident Types ICON plc vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for ICON plc in 2025.

Incident History — ICON plc (X = Date, Y = Severity)

ICON plc cyber incidents detection timeline including parent company and subsidiaries

ICON plc Company Subsidiaries

SubsidiaryImage

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Loading...
similarCompanies

ICON plc Similar Companies

Charles River Laboratories

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an

Thermo Fisher Scientific

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr

Agilent Technologies

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product

The National Institutes of Health

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an

Syneos Health

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w

Gilead Sciences

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac

newsone

ICON plc CyberSecurity News

December 09, 2025 02:16 PM
ICON plc Releases Findings from Two Biotech Sector Survey

ICON plc released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of 2023...

December 02, 2025 08:00 AM
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

DUBLIN, December 02, 2025--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest...

November 21, 2025 08:00 AM
Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound?

Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

November 12, 2025 08:00 AM
ICON plc to Present at the Jefferies London Healthcare Conference

DUBLIN, November 12, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that...

November 07, 2025 08:00 AM
Ronald Muhlenkamp's Strategic Move: Icon PLC Takes Center Stage with 3.49% Portfolio Share

Exploring Ronald Muhlenkamp (Trades, Portfolio)'s Latest 13F Filing and Investment Strategies.

November 03, 2025 08:00 AM
Cybersecurity Policy Gets Real at Aspen Policy Academy

Betsy Cooper, a Yale-trained lawyer with Oxford degrees, entered cybersecurity by chance. She's now a crucial advocate for businesses and...

October 23, 2025 07:00 AM
Icon PLC (ICLR) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Competitive Pressures

Icon PLC (ICLR) reports steady revenue growth and robust cash flow, while addressing margin pressures and competitive challenges in the...

October 22, 2025 07:00 AM
Icon PLC (ICLR) Surpasses Q3 Earnings and Revenue Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of +0.91% and +3.03%, respectively, for the quarter ended September 2025.

October 22, 2025 07:00 AM
ICON Reports Third Quarter 2025 Results

Highlights. Quarter three revenue was $2,042.8 million representing an increase of 1.3% on quarter two 2025. Net income for the quarter was...

faq

Frequently Asked Questions

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.

ICON plc CyberSecurity History Information

Official Website of ICON plc

The official website of ICON plc is http://www.iconplc.com.

ICON plc’s AI-Generated Cybersecurity Score

According to Rankiteo, ICON plc’s AI-generated cybersecurity score is 795, reflecting their Fair security posture.

How many security badges does ICON plc’ have ?

According to Rankiteo, ICON plc currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Does ICON plc have SOC 2 Type 1 certification ?

According to Rankiteo, ICON plc is not certified under SOC 2 Type 1.

Does ICON plc have SOC 2 Type 2 certification ?

According to Rankiteo, ICON plc does not hold a SOC 2 Type 2 certification.

Does ICON plc comply with GDPR ?

According to Rankiteo, ICON plc is not listed as GDPR compliant.

Does ICON plc have PCI DSS certification ?

According to Rankiteo, ICON plc does not currently maintain PCI DSS compliance.

Does ICON plc comply with HIPAA ?

According to Rankiteo, ICON plc is not compliant with HIPAA regulations.

Does ICON plc have ISO 27001 certification ?

According to Rankiteo,ICON plc is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Industry Classification of ICON plc

ICON plc operates primarily in the Biotechnology Research industry.

Number of Employees at ICON plc

ICON plc employs approximately 36,427 people worldwide.

Subsidiaries Owned by ICON plc

ICON plc presently has no subsidiaries across any sectors.

ICON plc’s LinkedIn Followers

ICON plc’s official LinkedIn profile has approximately 577,622 followers.

NAICS Classification of ICON plc

ICON plc is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

ICON plc’s Presence on Crunchbase

Yes, ICON plc has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/icon-plc.

ICON plc’s Presence on LinkedIn

Yes, ICON plc maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/icon-plc-2.

Cybersecurity Incidents Involving ICON plc

As of December 14, 2025, Rankiteo reports that ICON plc has not experienced any cybersecurity incidents.

Number of Peer and Competitor Companies

ICON plc has an estimated 4,489 peer or competitor companies worldwide.

ICON plc CyberSecurity History Information

How many cyber incidents has ICON plc faced ?

Total Incidents: According to Rankiteo, ICON plc has faced 0 incidents in the past.

What types of cybersecurity incidents have occurred at ICON plc ?

Incident Types: The types of cybersecurity incidents that have occurred include .

Incident Details

What are the most common types of attacks the company has faced ?

Additional Questions

cve

Latest Global CVEs (Not Company-Specific)

Description

A weakness has been identified in itsourcecode Online Pet Shop Management System 1.0. This vulnerability affects unknown code of the file /pet1/addcnp.php. This manipulation of the argument cnpname causes sql injection. The attack can be initiated remotely. The exploit has been made available to the public and could be exploited.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in Tenda AX9 22.03.01.46. This affects the function image_check of the component httpd. The manipulation results in use of weak hash. It is possible to launch the attack remotely. A high complexity level is associated with this attack. It is indicated that the exploitability is difficult. The exploit has been released to the public and may be exploited.

Risk Information
cvss2
Base: 2.6
Severity: HIGH
AV:N/AC:H/Au:N/C:N/I:P/A:N
cvss3
Base: 3.7
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A weakness has been identified in code-projects Student File Management System 1.0. This issue affects some unknown processing of the file /admin/update_student.php. This manipulation of the argument stud_id causes sql injection. The attack is possible to be carried out remotely. The exploit has been made available to the public and could be exploited.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in code-projects Student File Management System 1.0. This vulnerability affects unknown code of the file /admin/save_user.php. The manipulation of the argument firstname results in sql injection. The attack can be executed remotely. The exploit has been released to the public and may be exploited.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in code-projects Student File Management System 1.0. This affects an unknown part of the file /admin/update_user.php. The manipulation of the argument user_id leads to sql injection. Remote exploitation of the attack is possible. The exploit is publicly available and might be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=icon-plc-2' -H 'apikey: YOUR_API_KEY_HERE'

What Do We Measure ?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge